Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Etripamil_140 mg	35
Overall Study	STARTED	Etripamil_ 105 mg	41
Overall Study	STARTED	Etripamil_70 mg	35
Overall Study	STARTED	Etripamil_35 mg	43
Overall Study	STARTED	Placebo	36
Overall Study	STARTED	Open-label Etripamil 70 mg	9
Overall Study	COMPLETED	Etripamil_140 mg	21
Overall Study	COMPLETED	Etripamil_ 105 mg	20
Overall Study	COMPLETED	Etripamil_70 mg	23
Overall Study	COMPLETED	Etripamil_35 mg	20
Overall Study	COMPLETED	Placebo	20
Overall Study	COMPLETED	Open-label Etripamil 70 mg	9
Overall Study	NOT COMPLETED	Etripamil_140 mg	14
Overall Study	NOT COMPLETED	Etripamil_ 105 mg	21
Overall Study	NOT COMPLETED	Etripamil_70 mg	12
Overall Study	NOT COMPLETED	Etripamil_35 mg	23
Overall Study	NOT COMPLETED	Placebo	16
Overall Study	NOT COMPLETED	Open-label Etripamil 70 mg	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02296190/flow